Incidence of Low Seroimmunity to Hepatitis B Virus in Children With Inflammatory Bowel Disease
Authors:
- 1 November 2017
- journal article
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 65 (5) , 551-554
Abstract
Objectives: Patients with inflammatory bowel disease (IBD) often receive immunosuppressive therapy, which may make them vulnerable to infections such as hepatitis B. We hypothesized that hepatitis B virus titers are low in the vaccinated pediatric population with IBD. The aims of our study were to identify the incidence of lower titers of hepatitis B surface antibody (HBsAb) and determine which patient factors may be associated with lower HBsAb titers.Methods: Patients with diagnosis of IBD, ages 5 to 18 years, were prospectively enrolled. Patients were confirmed to have had a full series of hepatitis B vaccination. Quantitative serum HBsAb titers were measured and logistic regression analysis with independent variables of age, sex, race, disease phenotype, surgery, medications and a dependent variable of adequate HBsAb titers (> 10 mIU/mL) was performed.Results: Of the 116 patients enrolled, 57 were boys and 59 were girls. 75 patients had a diagnosis of Crohn disease; 32 had a diagnosis of ulcerative colitis; and 9 patients had been diagnosed as having indeterminate colitis. At the time of the study, 15 patients were taking corticosteroid, 66 on an immunomodulator, and 53 on a biologic. Sixty percent of patients in the 5‐ to 10‐year age group had protective titers versus 22% to 27% in the older groups, P = 0.04. Only 28% of the 116 patients had HBsAb titers of >10m IU/mL. Twenty percent of the patients taking corticosteroids, 27% taking immunomodulators, and 24% taking biologics were found to be seroimmune.Conclusions: Nearly two‐thirds of pediatric patients with IBD have low titers against hepatitis B virus. Titers were highest in the younger patients. No patient‐specific variable, such as the use of immunosuppressants, appeared to influence these low titers.Keywords
This publication has 36 references indexed in Scilit:
- Anti-TNF treatment blocks the induction of T cell-dependent humoral responsesAnnals of the Rheumatic Diseases, 2013
- Viral Infections in Patients With Inflammatory Bowel Disease on ImmunosuppressantsThe American Journal of the Medical Sciences, 2012
- Antibody Levels and Protection after Hepatitis B Vaccine: Results of a 22‐Year Follow‐Up Study and Response to a Booster DoseThe Journal of Infectious Diseases, 2009
- Chronic hepatitis B: Update 2009 #Hepatology, 2009
- Persistence of Protection Against Hepatitis B Virus Infection Among Adolescents Vaccinated With Recombinant Hepatitis B Vaccine Beginning at BirthThe Pediatric Infectious Disease Journal, 2008
- Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosisGut, 2008
- Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescentsVaccine, 2007
- Chronic hepatitis B reactivation following infliximab therapy in Crohn’s disease patients: need for primary prophylaxisGut, 2004
- Hepatitis B vaccinesJournal of Hepatology, 2003
- Protection Provided by Hepatitis B Vaccine in a Yupik Eskimo Population--Results of a 10-Year StudyThe Journal of Infectious Diseases, 1997